Cargando…

Preclinical safety evaluation of hepatic arterial infusion of oncolytic poxvirus

PURPOSE: Oncolytic poxvirus has shown promise in treating various solid tumors, such as liver cancer, and administration of oncolytic poxvirus via the hepatic artery may provide more survival benefits than other routes of administration. However, there is a lack of safety information to guide the ap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cho, Euna, Ryu, Eun Jin, Jiang, Fen, Jeon, Ung Bae, Cho, Mong, Kim, Cy Hyun, Kim, Miyoung, Kim, Nam Deuk, Hwang, Tae-Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6087018/ https://www.ncbi.nlm.nih.gov/pubmed/30122903 http://dx.doi.org/10.2147/DDDT.S171269

Ejemplares similares

Characterization of Oncolytic Vaccinia Virus Harboring the Human IFNB1 and CES2 Transgenes
por: Cho, Euna, et al.
Publicado: (2020)

Engineering and Preclinical Evaluation of Western Reserve Oncolytic Vaccinia Virus Expressing A167Y Mutant Herpes Simplex Virus Thymidine Kinase
por: Islam, S. M. Bakhtiar UL, et al.
Publicado: (2020)

Effect of aldosterone on the amplification of oncolytic vaccinia virus in human cancer lines
por: Lee, Hyun Ju, et al.
Publicado: (2011)

Oncolytic properties of non-vaccinia poxviruses
por: Ricordel, Marine, et al.
Publicado: (2018)

A cautionary note on the selectivity of oncolytic poxviruses
por: Tang, Bingtao, et al.
Publicado: (2019)

Cowpox Virus: A New and Armed Oncolytic Poxvirus
por: Ricordel, Marine, et al.
Publicado: (2017)

Oncolytic and immunostimulatory efficacy of a targeted oncolytic poxvirus expressing human GM-CSF following intravenous administration in a rabbit tumor model
por: Lee, J-H, et al.
Publicado: (2009)

A comprehensive preclinical study supporting clinical trial of oncolytic chimeric poxvirus CF33-hNIS-anti-PD-L1 to treat breast cancer
por: Chaurasiya, Shyambabu, et al.
Publicado: (2021)

Plug-assisted retrograde transvenous obliteration via gastrocaval shunt for the gastric variceal bleeding: A case report
por: Jang, Joo Yeon, et al.
Publicado: (2021)

Rapid Generation of Multiple Loci-Engineered Marker-free Poxvirus and Characterization of a Clinical-Grade Oncolytic Vaccinia Virus
por: Guo, Zong Sheng, et al.
Publicado: (2017)

Targeting Poxvirus Decapping Enzymes and mRNA Decay to Generate an Effective Oncolytic Virus
por: Burgess, Hannah M., et al.
Publicado: (2018)

The Oncolytic Poxvirus JX-594 Selectively Replicates in and Destroys Cancer Cells Driven by Genetic Pathways Commonly Activated in Cancers
por: Parato, Kelley A, et al.
Publicado: (2012)

An Oncolytic Poxvirus Encoding hNIS, Shows Antitumor Efficacy and Allows Tumor Imaging in a Liver Cancer Model
por: Chaurasiya, Shyambabu, et al.
Publicado: (2023)

TRAIL Gene-Armed Oncolytic Poxvirus and Oxaliplatin Can Work Synergistically against Colorectal Cancer
por: Ziauddin, Mohammed F, et al.
Publicado: (2010)

The Combination of Immunosuppression and Carrier Cells Significantly Enhances the Efficacy of Oncolytic Poxvirus in the Pre-Immunized Host
por: Guo, Z. Sheng, et al.
Publicado: (2010)

Phase 1 Study of Intravenous Oncolytic Poxvirus (vvDD) in Patients With Advanced Solid Cancers
por: Downs-Canner, Stephanie, et al.
Publicado: (2016)

Assembly mechanism of the pleomorphic immature poxvirus scaffold
por: Hyun, Jaekyung, et al.
Publicado: (2022)

CXCL11-Armed oncolytic poxvirus elicits potent antitumor immunity and shows enhanced therapeutic efficacy
por: Liu, Zuqiang, et al.
Publicado: (2015)

Arming viruses in multi-mechanistic oncolytic viral therapy: current research and future developments, with emphasis on poxviruses
por: Sampath, Padma, et al.
Publicado: (2013)

Vaccinia Virus Shuffling: deVV5, a Novel Chimeric Poxvirus with Improved Oncolytic Potency
por: Ricordel, Marine, et al.
Publicado: (2018)

Poxvirus tropism
por: McFadden, Grant
Publicado: (2005)

Poxvirus Recombination
por: Evans, David Hugh
Publicado: (2022)

Zoonotic poxviruses()
por: Essbauer, Sandra, et al.
Publicado: (2010)

Oncolytic Viruses and Immune Checkpoint Inhibitors: Preclinical Developments to Clinical Trials
por: Hwang, June Kyu, et al.
Publicado: (2020)

The Evolution of Poxvirus Vaccines
por: Sánchez-Sampedro, Lucas, et al.
Publicado: (2015)

Decoding poxvirus genome
por: Yang, Zhilong, et al.
Publicado: (2015)

Oncolytic Poxvirus Armed with Fas Ligand Leads to Induction of Cellular Fas Receptor and Selective Viral Replication in FasR Negative Cancer
por: Sathaiah, Magesh, et al.
Publicado: (2011)

Gene expression profiling of hematologic malignant cell lines resistant to oncolytic virus treatment
por: Lee, Nam Hee, et al.
Publicado: (2016)

Chemopreventive and chemotherapeutic effects of genistein, a soy isoflavone, upon cancer development and progression in preclinical animal models
por: Kim, Seung-Hee, et al.
Publicado: (2014)

Poxvirus-based vaccine therapy for patients with advanced pancreatic cancer
por: Kaufman, Howard L, et al.
Publicado: (2007)

Stent graft treatment of an ilioenteric fistula secondary to radiotherapy: a case report
por: Jang, Joo Yeon, et al.
Publicado: (2021)

A safer poxvirus vaccine
por: Bashyam, Hema
Publicado: (2008)

Lipid Membranes in Poxvirus Replication
por: Laliberte, Jason P., et al.
Publicado: (2010)

Detection of Infectious Poxvirus Particles
por: Nitsche, Andreas, et al.
Publicado: (2006)

Prevention of poxvirus infection by tetrapyrroles
por: Chen-Collins, Avril RM, et al.
Publicado: (2003)

NK cells and poxvirus infection
por: Burshtyn, Deborah N.
Publicado: (2013)

Poxviruses in Bats … so What?
por: Baker, Kate S., et al.
Publicado: (2014)

Suppression of Poxvirus Replication by Resveratrol
por: Cao, Shuai, et al.
Publicado: (2017)

Infections humaines à poxvirus()
por: Bohelay, G., et al.
Publicado: (2019)

Cidofovir in the treatment of poxvirus infections
por: De Clercq, Erik
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_bohdsv6s13lrmbmgqdrsjt6udr